These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28528452)

  • 1. Tumor suppressor protein p53 exerts negative transcriptional regulation on human sodium iodide symporter gene expression in breast cancer.
    Kelkar MG; Thakur B; Derle A; Chatterjee S; Ray P; De A
    Breast Cancer Res Treat; 2017 Aug; 164(3):603-615. PubMed ID: 28528452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of human sodium iodide symporter gene therapy for breast cancer by HDAC inhibitor mediated transcriptional modulation.
    Kelkar MG; Senthilkumar K; Jadhav S; Gupta S; Ahn BC; De A
    Sci Rep; 2016 Jan; 6():19341. PubMed ID: 26777440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sodium/iodide symporter NIS is a transcriptional target of the p53-family members in liver cancer cells.
    Guerrieri F; Piconese S; Lacoste C; Schinzari V; Testoni B; Valogne Y; Gerbal-Chaloin S; Samuel D; Bréchot C; Faivre J; Levrero M
    Cell Death Dis; 2013 Sep; 4(9):e807. PubMed ID: 24052075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription factor Nkx-2.5 induces sodium/iodide symporter gene expression and participates in retinoic acid- and lactation-induced transcription in mammary cells.
    Dentice M; Luongo C; Elefante A; Romino R; Ambrosio R; Vitale M; Rossi G; Fenzi G; Salvatore D
    Mol Cell Biol; 2004 Sep; 24(18):7863-77. PubMed ID: 15340050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wild-Type P53 Induces Sodium/Iodide Symporter Expression Allowing Radioiodide Therapy in Anaplastic Thyroid Cancer.
    Liu L; Li D; Chen Z; Yang J; Ma Y; Cai H; Shan C; Lv Z; Zhang X
    Cell Physiol Biochem; 2017; 43(3):905-914. PubMed ID: 28957796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo radioiodide imaging and treatment of breast cancer xenografts after MUC1-driven expression of the sodium iodide symporter.
    Dwyer RM; Bergert ER; O'connor MK; Gendler SJ; Morris JC
    Clin Cancer Res; 2005 Feb; 11(4):1483-9. PubMed ID: 15746050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of retinoic acid-induced functional sodium iodide symporter (NIS) expression and cytotoxicity of ¹³¹I by carbamazepine in breast cancer cells.
    Willhauck MJ; O Kane DJ; Wunderlich N; Göke B; Spitzweg C
    Breast Cancer Res Treat; 2011 Jan; 125(2):377-86. PubMed ID: 20300827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visualization of endogenous p53-mediated transcription in vivo using sodium iodide symporter.
    Kim KI; Chung JK; Kang JH; Lee YJ; Shin JH; Oh HJ; Jeong JM; Lee DS; Lee MC
    Clin Cancer Res; 2005 Jan; 11(1):123-8. PubMed ID: 15671536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cell-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene.
    Knoop K; Schwenk N; Schmohl K; Müller A; Zach C; Cyran C; Carlsen J; Böning G; Bartenstein P; Göke B; Wagner E; Nelson PJ; Spitzweg C
    J Nucl Med; 2015 Apr; 56(4):600-6. PubMed ID: 25745085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of iodide uptake and sodium/iodide symporter expression in the mcf-7 human breast cancer cell line.
    Arturi F; Ferretti E; Presta I; Mattei T; Scipioni A; Scarpelli D; Bruno R; Lacroix L; Tosi E; Gulino A; Russo D; Filetti S
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2321-6. PubMed ID: 15623812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.
    Kogai T; Taki K; Brent GA
    Endocr Relat Cancer; 2006 Sep; 13(3):797-826. PubMed ID: 16954431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sodium/iodide symporter (NIS)-mediated radioiodine therapy on estrogen receptor-negative breast cancer.
    Yao C; Pan Y; Li Y; Xu X; Lin Y; Wang W; Wang S
    Oncol Rep; 2015 Jul; 34(1):59-66. PubMed ID: 25955347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer.
    Kakinuma H; Bergert ER; Spitzweg C; Cheville JC; Lieber MM; Morris JC
    Cancer Res; 2003 Nov; 63(22):7840-4. PubMed ID: 14633711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression.
    Spitzweg C; Baker CH; Bergert ER; O'Connor MK; Morris JC
    Hum Gene Ther; 2007 Oct; 18(10):916-24. PubMed ID: 17931047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sterol regulatory element-binding proteins are regulators of the sodium/iodide symporter in mammary epithelial cells.
    Wen G; Pachner LI; Gessner DK; Eder K; Ringseis R
    J Dairy Sci; 2016 Nov; 99(11):9211-9226. PubMed ID: 27614840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced expression of adenovirus-mediated sodium iodide symporter gene in MCF-7 breast cancer cells with retinoic acid treatment.
    Lim SJ; Paeng JC; Kim SJ; Kim SY; Lee H; Moon DH
    J Nucl Med; 2007 Mar; 48(3):398-404. PubMed ID: 17332617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pan-DAC inhibitor LBH589 is a multi-functional agent in breast cancer cells: cytotoxic drug and inducer of sodium-iodide symporter (NIS).
    Fortunati N; Catalano MG; Marano F; Mugoni V; Pugliese M; Bosco O; Mainini F; Boccuzzi G
    Breast Cancer Res Treat; 2010 Dec; 124(3):667-75. PubMed ID: 20213084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of transcriptional activity of the oestrogen receptor with sodium iodide symporter as an imaging reporter gene.
    Kang JH; Chung JK; Lee YJ; Kim KI; Jeong JM; Lee DS; Lee MC
    Nucl Med Commun; 2006 Oct; 27(10):773-7. PubMed ID: 16969258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-lipoic acid induces sodium iodide symporter expression in TPC-1 thyroid cancer cell line.
    Choi HJ; Kim TY; Ruiz-Llorente S; Jeon MJ; Han JM; Kim WG; Shong YK; Kim WB
    Nucl Med Biol; 2012 Nov; 39(8):1275-80. PubMed ID: 22995901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous expression of the sodium iodide symporter mediates uptake of iodide in murine models of colorectal carcinoma.
    Gaertner FC; Rohde F; Mueller J; Blechert B; Janssen KP; Essler M
    Int J Cancer; 2009 Dec; 125(12):2783-91. PubMed ID: 19569179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.